ECTMIH 2015: European congress on tropical medicine and international health ECTMIH

September 06, 2015

At more than 50 events on highly topical issues such as the spread of drug resistance, dealing with sporadic infectious diseases such as Ebola, and the new UN sustainability goals, participants strive for the most innovative solutions and implementation strategies for improving global health.

"We need the best science for those most neglected on a global level," says Marcel Tanner, the recently resigned Director of the Swiss Tropical and Public Health Institute, Swiss TPH, and president of the scientific committee of the conference.

The Swiss Tropical and Public Health Institute, Swiss TPH, is organizing the congress at the Congress Center Basel, Switzerland.

New Platforms for Effective Solutions Global health remains one of the burning issues in international cooperation. The UN sustainable development goals (SDGs) to be adopted at the end of September include global health as a central issue. Thanks to intensive cooperation via private-public partnerships between science, the public sector, foundations, and the private sector, new approaches and treatments for even neglected diseases are being developed.

"We need platforms such as this congress, which better connects the various players from the fields of research, implementation, and policy and leads to concrete solutions," says Marcel Tanner. New knowledge from research, local know-how, and financial and human resources need to be pooled and shared. The Congress in Basel takes place out of the conviction that we can make an active and effective contribution.

The topics discussed during the five days cover a wide range, from issues of increased global mobility and growing social and political instability, to the environment and health, population growth, diseases of poverty, social and economic determinants of health and well-being, and the benefit of 'Big Data' in health monitoring and prevention.

High-ranking Representatives of the WHO, EU, and Switzerland will open the Conference The conference organized by the Swiss Tropical and Public Health Institute Swiss TPH will be opened in an official ceremony in the Basel Fair with representatives from the fields of politics, science, and health on Sunday, 4th September. High-level WHO representatives, such as the WHO Regional Director for Africa, Matshidiso Moeti will be taking part. The world's most important institutions in the field of global health will be represented at the congress

Swiss Tropical and Public Health Institute

Related Drug Resistance Articles from Brightsurf:

New drug that can prevent the drug resistance and adverse effects
A research team in Korea is garnering attention for having developed an anticancer drug that could potentially prevent drug resistance.

New drug combinations help overcome resistance to immunotherapy
A new study from researchers at the UCLA Jonsson Comprehensive Cancer Center helps explain how disruptions in genes can lead to the resistance to one of the leading immunotherapies, PD-1 blockade, and how new drug combinations could help overcome resistance to the anti-PD-1 therapy in a mechanistically-based way.

Drug overcomes chemotherapy resistance in ovarian cancer
In an international preclinical study, researchers found they could overcome chemotherapy resistance in clear cell ovarian cancer cell models using low doses of the drug 2-deoxy-D-glucose.

Engineers model mutations causing drug resistance
Whether it is a drug-resistant strain of bacteria, or cancer cells that no longer react to the drugs intended to kill them, diverse mutations make cells resistant to chemicals, and 'second generation' approaches are needed.

Double success for University drug resistance research
Swansea University research into the threat posed by antifungal drug resistance has been highlighted in two prestigious international journals.

What fuels a 'domino effect' in cancer drug resistance?
KAIST researchers have identified mechanisms that relay prior acquired resistance to the first-line chemotherapy to the second-line targeted therapy, fueling a 'domino effect' in cancer drug resistance.

New flu drug drives drug resistance in influenza viruses
University of Wisconsin-Madison researchers examined the effects of baloxavir treatment on influenza virus samples collected from patients before and after treatment.

Resistance to last resort drug arose in patient over 3 weeks
French investigators have described development of resistance to one of the last resort therapies used to treat extremely drug-resistant Pseudomonas aeruginosa.

Cause of drug resistance in a drug resistance in intestinal tumors identified
Researchers clarify mechanisms that allow hard-to-treat cancers to develop, and have identified strategies that could lead to new therapies.

Engineered viruses could fight drug resistance
MIT biological engineers can program bacteriophages to kill different strains of E. coli by making mutations in the protein that the viruses use to bind to host cells.

Read More: Drug Resistance News and Drug Resistance Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to